Search Results - fu-shin yu




3 Results Sort By:
Topical treatment with TGFbeta3 to facilitate skin and corneal wound healing in diabetic patients
Topical Treatment with TGFb3 to Facilitate Skin and Corneal Wound Healing in Diabetic Patients WSU Tech#: 14-1207 Technology Summary: TGFb3 has been implicated in the reduction of scar formation in wound healing. Renovo Group PLC, is a European based biopharmaceutical company developing drugs to reduce scaring, improve wound healing and enhance...
Published: 2/10/2017   |   Inventor(s): Fu-Shin Yu
Keywords(s):  
Category(s): Medical, Biologicals, Biomedical, Drug Discovery, Metabolic disorders, Protein/peptides, Therapeutics, Life Science
Topical IL-1Ra (anakinra) in the form of gel to treat persistent diabetic skin and corneal wounds
BackgroundAnakinra (aka. Kineret) is a recombinant human IL-1Ra that was developed by Amgen. It is currently used to treat moderately to severely active rheumatoid arthritis, but also treats neonatal-onset multisystem inflammatory disease (NOMID). Anakinra is given as an IV dose and the drug is no longer under patent. The properties of Anakinra a...
Published: 5/25/2016   |   Inventor(s): Fu-Shin Yu
Keywords(s):  
Category(s): Biologicals, Drug Discovery, Pharmaceuticals, Therapeutics
Using Flagellin to Prevent and to Treat Inflammation Associated Gram Negative Bacterial Infection
Detailed Description The existence of multipotent stem cells within the adult brain has been debated for some time. While the identity of this cell has been unknown it is clear that stem cells reside in specialized tissue (subventricular zone and subgranular zone) and that local microenvironments regulate their differentiation and self-renewal....
Published: 5/18/2010   |   Inventor(s): Fu-Shin Yu, Ashok Kumor, Jing Zhang, Linda Hazlett
Keywords(s): Anti-microbial, Asthma
Category(s): Therapeutics, Diseases, Life Science, Infectious disease